REVB

Revelation Biosciences

REVBW3

Penny Stock

$0.01arrow_drop_up0.83%$0.00

Penny Stock

REVB

REVBW3

$0.01

arrow_drop_up0.83%$0.00

Penny Stock

Performance History

Key Stats
Open	$0.01
Prev. Close	$0.01
EPS	-4.77
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$0.00
PE Ratio	-

	LOW	HIGH
Day Range	0.01	0.01
52 Week Range	0.00	0.04

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-4.77

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Revelation Biosciences (REVBW)

Revelation Biosciences, Inc. (REVBW) is a biotechnology company specializing in the development and commercialization of innovative therapies for a range of diseases. The company's focus is on identifying and leveraging novel biological pathways to develop targeted therapies that can address unmet medical needs. With a strong pipeline of potential drug candidates, Revelation Biosciences is poised to make a significant impact in the biotech industry.

The stock price history of Revelation Biosciences, Inc. (REVBW) shows a steady upward trend over the past year. This reflects the market's confidence in the company's ability to deliver on its promises and generate value for its shareholders. The stock has experienced both periods of consolidation and periods of growth, demonstrating its resilience and potential for long-term success.

Sector
Industry
CEO
Headquarters
Employees: 0
Exchange: NASDAQ

Keep an eye on Revelation Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Revelation Biosciences's (REVBW) price per share?

The current price per share for Revelation Biosciences (REVBW) is $0.01. The stock has seen a price change of $0 recently, indicating a 0.83% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Revelation Biosciences (REVBW)?

For Revelation Biosciences (REVBW), the 52-week high is $0.04, which is 241.32% from the current price. The 52-week low is $0.01, the current price is 132.69% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Revelation Biosciences (REVBW) a growth stock?

Revelation Biosciences (REVBW) has shown an average price growth of -3.66% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Revelation Biosciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Revelation Biosciences (REVBW) stock price performance year to date (YTD)?

As of the latest data, Revelation Biosciences (REVBW) has a year-to-date price change of 14.15%. Over the past month, the stock has experienced a price change of -4.72%. Over the last three months, the change has been -14.79%. Over the past six months, the figure is -15.19%.

help

Is Revelation Biosciences (REVBW) a profitable company?

Revelation Biosciences (REVBW) has a net income of -$120.25K, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$8.66M. Furthermore, the EBITDA is -$8.52M.

help

What is the market capitalization of Revelation Biosciences (REVBW)?

Revelation Biosciences (REVBW) has a market capitalization of $0. The average daily trading volume is 0.01, indicating the stock's liquidity and investor engagement.